Genetic testing and Alzheimer disease: The promise

Alzheimer Disease and Associated Disorders

Volumn 12, Issue SUPPL. 3, 1998, Pages

  Roses, Allen D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

APOE; Dementia; Diagnosis; Genotyping; Predictive test; Susceptibility

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; PREDICTION; PRIORITY JOURNAL;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS A; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 0032459519     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Bird TD. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view (Editorial). Ann Neurol 1995;38:2-3.
2. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 1994;7:180-4.
3. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
4. Farrer LA, Brin MF, Elsas L, et al. Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/ American Society of Human Genetics Working Group on ApoE and Alzheimer disease. JAMA 1995;274:1627-9.
5. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-6.
6. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105.
7. Levy-Lehad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269: 973-7.
8. Lucotte G, Aouizerate A, Gerard N, Turpin JC, Landais P. Allele doses of apolipoprotein E type epsilon-4 in sporadic late-onset Alzheimer's disease. Am J Med Genet 1995;60:566-9.
9. Maestre G, Oilman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37: 254-9.
10. Mahieux F, Couderc R, Moulignier A, Bailleul S, Porabinek N, Laudet J. Isoform 4 of apolipoprotein E and Alzheimer disease. Specificity and clinical study. Rev Neurol (Paris) 1995;151:231-9.
11. Mayeux R, Ottman R, Maestre G, et al. Synergistic effects of traumatic head injury and apolipoprotein-∈4 in patients with Alzheimer's disease. Neurology 1995;45:555-7.
12. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med 1998;338:506-11.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
14. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
15. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994;36: 889-95.
16. Okuizumi K, Onodera O, Tanaka H, et al. ApoE-epsilon 4 and early-onset Alzheimer's. Nature Genet 1994;7:10-1.
17. Pericak-Vance MA, Bebout JL, Gaskell PJ, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-50.
18. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
19. Poirier J, Delisle MC, Quirion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Nat Acad Sci USA 1995;92:12260-4.
20. Reiman EM, Caselli RJ, Lang S, et al. Preclinical evidence of a genetic risk factor for Alzheimer's disease in apolipoprotein E type 4 homozygotes using positron emission tomography. N Engl J Med 1996; 334:752-8.
21. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996;334:752-8.
22. Relkin NR. Consensus statement: apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996;347:1091-5.
23. Rogaev E, Sherrington R, Rogaeva E, et al. Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376: 600-2.
24. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease [Review]. J Neuropathol Exp Neurol 1994;53:429-37.
25. Roses AD. Apolipoprotein E genotyping in differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995a;38:6-14.
26. Roses AD. Perspective: on the metabolism of apolipoprotein E and the Alzheimer diseases. Exp Neurol 1995b;132:149-56.
27. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer disease. Annu Rev Med 1996;47:387-400.
28. Roses AD. Genetic testing for Alzheimer disease. Practical and ethical issues. Arch Neurol 1997;54:1226-9.
29. Roses AD, Devlin B, Conneally PM, et al. Measuring the genetic contribution of APOE in late-onset Alzheimer disease. Am J Hum Genet 1995;57(4):A202.
30. Roses AD, Strittmatter WJ, Pericak VM, Corder EH, Saunders AM, Schmechel DE. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet 1994;343:1564-5.
31. Saunders AM, Hulette C, Welsh KA, et al. Specificity, sensitivity and predictive value of apolipoprotein E genotyping in a consecutive autopsy series of sporadic Alzheimer disease. Lancet 1996;348(9020):90-3.
32. Saunders AM, Schmader K, Breitner JC, et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993a;342:710-1.
33. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993b;43:1467-72.
34. Selkoe DJ. Alzheimer's disease: a central role for amyloid [Review]. J Neuropathol Exp Neurol 1994;53:438-47.
35. Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Arch Neurol 1995;52:1074-9.
36. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60.
37. Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995;273:942-7.
38. Sorbi S, Nacmias B, Forleo P, Piacentini S, Latorraca S, Amaducci L. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol 1995;38:124-7.
39. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Nat Acad Sci USA 1993;90:1977-81.
40. St. George-Hyslop P, McLachlan DC, Tsuda T, et al. Alzheimer's disease and possible gene interaction Science 1994;263:537. [Published erratum appears in Science 1994 Feb 18;263:904.]
41. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993;163:66-8.
42. Van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994;7:74-8.
43. Welsh-Bohmer KA, Gearing M, Saunders AM, Roses AD, Mirra S. Apolipoprotein E genotypes in a neuropathological series from the Consortium toEstablish a Registry for Alzheimer's Disease. Ann Neurol 1997;42:319-25.
44. Yoshizawa T, Yamakawa KK, Komatsuzaki Y, et al. Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 1994;36:656-9.